Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2025-01-20 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 77353

Date	Daily Closing Price	Open	High	Low	Volume
20 Mon Jan 2025	2135.50	2065.00	2149.50	2048.00	1.446 times
17 Fri Jan 2025	2063.30	2050.00	2069.70	2013.85	1.331 times
16 Thu Jan 2025	2053.05	2052.00	2069.20	2013.30	0.78 times
15 Wed Jan 2025	2042.50	2086.00	2116.40	1987.00	1.468 times
14 Tue Jan 2025	2072.05	2100.05	2118.00	2051.00	0.856 times
13 Mon Jan 2025	2093.35	2143.00	2165.80	2078.95	1.073 times
10 Fri Jan 2025	2190.40	2208.35	2213.90	2141.35	1.153 times
09 Thu Jan 2025	2208.35	2201.00	2231.00	2201.00	0.443 times
08 Wed Jan 2025	2208.00	2231.10	2241.55	2185.10	0.708 times
07 Tue Jan 2025	2231.10	2232.00	2239.90	2188.80	1.25 times

My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2108 as stoploss in an intra day buy trade for a target of 2184.81. However, stock will show a bearish move below 2108.

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	1987.00
Downside Target	2048.00
Upside Target	2141.35
Upside Target	2213.40
Upside Target	2292.65
Upside Target	2307.00
Upside Target	2457.75
Upside Target	2500.00
Upside Target	2676.25
Upside Target	2742.95
Upside Target	2889.90
Upside Target	2922.80

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	2072.5
Downside Intraday Target	2009.5
Upside Intraday Target	2174
Upside Intraday Target	2212.5
Downside Intraday Target	2111

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
20 Mon Jan 2025	2135.50	2065.00	2149.50	2048.00	0.262 times
17 Fri Jan 2025	2063.30	2143.00	2165.80	1987.00	1.227 times
10 Fri Jan 2025	2190.40	2236.00	2248.95	2141.35	0.751 times
03 Fri Jan 2025	2241.05	2274.45	2280.15	2158.40	3.053 times
27 Fri Dec 2024	2274.45	2275.95	2292.65	2213.40	0.362 times

Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
20 Mon Jan 2025	2135.50	2235.00	2272.00	1987.00	0.572 times
31 Tue Dec 2024	2251.85	2436.00	2457.75	2158.40	0.973 times
29 Fri Nov 2024	2444.40	2729.00	2742.95	2307.00	0.867 times
31 Thu Oct 2024	2712.25	2751.00	2889.90	2500.00	1.386 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.

MACD generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term and the sell signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Glaxosmithkline Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for Glaxosmithkline Pharmaceuticals in short term but BUY signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Glaxosmithkline Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2123.11 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.